Overview

Athenex, Inc. is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of cancer. The company's mission is to improve the lives of cancer patients by creating more effective, safer, and tolerable treatments. Athenex leverages its global infrastructure to deliver promising therapies through its robust R&D pipeline and strategic partnerships.

Therapeutic areas

FDA compliance signals

1 FDA enforcement record linked to this company.

  • 4832019-07-11

    Deviations from laboratory control requirements

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.